Tianjin Vancoein Biotechnology Co., Ltd. was founded in 2020. Since its establishment, the company has focused on the development, production, and sales of biological raw materials and in vitro diagnostic reagents. Relying on Hebei Normal University, West China Medical Center, Sichuan University, Beijing Institute of Technology and many other higher scientific research institutions, a highly educated and skilled research and development team has been established, and three platforms have been built - fluorescent immunochromatography platform, gold standard immunochromatography platform, and enzyme-linked immunization platform. Focusing on the development of products in the fields of immune diseases, infectious diseases, Respiratory disease, digestive tract diseases, blood screening, children's health, etc., to create a high-quality POCT brand.

The company has established a standardized GMP production workshop of 2900 square meters, with departments such as R&D, Quality, Marketing, Production, Administration and Human Resources, and Comprehensive Department. It has established a medical device quality management system that meets the requirements of laws and regulations such as ISO 13485.

We will adhere to the concept of "technology as the source, talent as the foundation, quality first, and customer satisfaction" to provide high-quality services to society.